EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic development and bioprinting of novel nanostructured multi-material bioinks for bone tissue engineering

Jannika T Korkeamäki iD, Ahmad Rashad iD, Miina Ojansivu iD, Jennika Karvinen iD, Janne T Koivisto iD, Kristin Syverud iD, Minna Kellomäki iD, Susanna Miettinen iD, Kamal Mustafa iD

Biofabrication · 01.04.2025 · 17 (2) · 025005

DOI: 10.1088/1758-5090/ada63b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biofabrication, online erschienen am 28.01.2025. Verfasst von Jannika T Korkeamäki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Bone Regeneration, Tissue Engineering, Bioprinting, Ink. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitetet i Bergen, Norges Forskningsråd, Olav Thon Stiftelsen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A functional bioink with potential in bone tissue engineering must be subjected to critical investigation throughout its intended lifespan. The aim of this study was to develop alginate–gelatin-based (Alg–Gel) multicomponent bioinks systematically and to assess the short- and long-term exposure responses of human bone marrow stromal cells (hBMSCs) printed within these bioinks with and without crosslinking. The first generation of bioinks was established by incorporating a range of cellulose nanofibrils (CNFs), to evaluate their effect on viscosity, printability and cell viability. Adding CNFs to Alg–Gel solution increased viscosity and printability without compromising cell viability. In the second generation of bioinks , the influence of nano-hydroxyapatite (nHA) on the performance of the optimized Alg–Gel-CNF formulation was investigated. The addition of nHA increased the viscosity and improved printability, and an adjustment in alginate concentration improved the stability of the structures in long-term culture. The third generation bioink incorporated RGD-functionalized alginate to support cell attachment and osteogenic differentiation. The optimized bioink composition exhibited improved printability, structural integrity in long-term culture and high hBMSC viability. In addition, the final bioink composition, RGD-Alg–Gel-CNF-nHA, showed osteogenic potential: production of the osteogenic marker proteins (Runx2, OCN), enzyme (ALP), and gene expression ( Runx2 , OCN ). A further aim of the study was to evaluate the osteogenic functionality of cells released from the structures after bioprinting. Cells were printed in two bioinks with different viscosities and incubated at 37 °C in growth medium without additional CaCl 2 . This caused gelatin to dissolve, releasing the cells to attach to tissue culture plates. The results demonstrated differences in hBMSC osteogenic differentiation. Moreover, the osteogenic differentiation of the released cells was different from that of the embedded cells cultured in 3D. Thus, this systematic investigation into bioink development shows improved results through the generations and sheds light on the biological effects of the bioprinting process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone RegenerationTissue EngineeringBioprintingInkHumansMesenchymal Stem CellsAlginatesGelatinNanostructuresDurapatiteCelluloseNanofibersOsteogenesisCell DifferentiationCells, CulturedCell Line

Stichwörter der Autor:innen

alginatecellulose nanofibrilsgelatinnano-hydroxyapatiteosteogenic differentiationprintabilityviscosity

Substanzen

AlginatesGelatinDurapatiteCellulose

Autor:innen und Institutionen

  • Center of Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
  • Biomaterials and Tissue Engineering Group, Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere, Finland.
  • RISE PFI, Trondheim, Norway.
  • Department of Chemical Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Tays Research Services, Wellbeing Services County of Pirkanmaa, Tampere University Hospital, Tampere, Finland.

ORCID-Profile: Jannika T Korkeamäki, Ahmad Rashad, Miina Ojansivu, Jennika Karvinen, Janne T Koivisto, Kristin Syverud, Minna Kellomäki, Susanna Miettinen, Kamal Mustafa

Förderung

  • Universitetet i Bergen
  • Norges Forskningsråd
  • Olav Thon Stiftelsen
  • Trond Mohn stiftelse
  • Research Council of Finland

Zitieren

APA

Korkeamäki, J. T., Rashad, A., Ojansivu, M., Karvinen, J., Koivisto, J. T., Syverud, K., Kellomäki, M., Miettinen, S., & Mustafa, K. (2025). Systematic development and bioprinting of novel nanostructured multi-material bioinks for bone tissue engineering. Biofabrication, 17(2), 025005. https://doi.org/10.1088/1758-5090/ada63b

Vancouver

Korkeamäki JT, Rashad A, Ojansivu M, Karvinen J, Koivisto JT, Syverud K, et al. Systematic development and bioprinting of novel nanostructured multi-material bioinks for bone tissue engineering. Biofabrication. 2025;17(2):025005. doi:10.1088/1758-5090/ada63b

BibTeX
@article{Korkeamki2025,
  author = {Korkeamäki, Jannika T and Rashad, Ahmad and Ojansivu, Miina and Karvinen, Jennika and Koivisto, Janne T and Syverud, Kristin and Kellomäki, Minna and Miettinen, Susanna and Mustafa, Kamal},
  title = {Systematic development and bioprinting of novel nanostructured multi-material bioinks for bone tissue engineering},
  journal = {Biofabrication},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {025005},
  doi = {10.1088/1758-5090/ada63b}
}
Kostenlos starten →